Pseudolumen Size and Perimeter in Prostate Cancer: Correlation with Patient Outcome

We demonstrated in 2011 that 61% of men with postoperative PSA failure had some cribriform pattern of prostate cancer, versus 16% of nonfailures ( OR=5.89, 𝑃<.0001). That study used digitized radical prostatectomy slides from 153 men, 76 fa...

Full description

Saved in:
Bibliographic Details
Main Authors: Kenneth A. Iczkowski, Kathleen C. Torkko, Gregory R. Kotnis, R. Storey Wilson, Wei Huang, Thomas M. Wheeler, Andrea M. Abeyta, M. Scott Lucia
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Prostate Cancer
Online Access:http://dx.doi.org/10.1155/2011/693853
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568401158995968
author Kenneth A. Iczkowski
Kathleen C. Torkko
Gregory R. Kotnis
R. Storey Wilson
Wei Huang
Thomas M. Wheeler
Andrea M. Abeyta
M. Scott Lucia
author_facet Kenneth A. Iczkowski
Kathleen C. Torkko
Gregory R. Kotnis
R. Storey Wilson
Wei Huang
Thomas M. Wheeler
Andrea M. Abeyta
M. Scott Lucia
author_sort Kenneth A. Iczkowski
collection DOAJ
description We demonstrated in 2011 that 61% of men with postoperative PSA failure had some cribriform pattern of prostate cancer, versus 16% of nonfailures ( OR=5.89, 𝑃<.0001). That study used digitized radical prostatectomy slides from 153 men, 76 failures (≥0.2 ng/mL) matched to 77 nonfailures. The current study's hypothesis: pseudolumen size and shape variability could stratify outcome within histologic patterns (single separate acini, separate acini with undulating lumens, fused small acini, papillary, cribriform). Pseudolumens were filled digitally on image captures from previously annotated specimens. Among all 5 patterns, pseudolumen spaces averaged smaller in failures than nonfailures. After multivariate analysis controlling for stage, age, margin, cancer amount, prostate volume, and presence of individual cells (grade 5), this retained significance only for the undulating-lumens and papillary patterns. In undulating-lumens pattern, PSA failures had smaller mean pseudolumen space sizes (𝑃=.03) but larger perimeters (𝑃=.04), implying more pseudolumen irregularity. In papillary pattern, the number of pseudolumen spaces was higher in failures (𝑃=.015), space size was smaller (𝑃=.11), perimeters were smaller (𝑃=.04), and perimeter/size ratio was higher (𝑃=.02). In conclusion, digitally measured pseudolumen size and shape may associate with outcome.
format Article
id doaj-art-fd376c8e8db24455b59a243e0249167b
institution Kabale University
issn 2090-3111
2090-312X
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Prostate Cancer
spelling doaj-art-fd376c8e8db24455b59a243e0249167b2025-02-03T00:59:09ZengWileyProstate Cancer2090-31112090-312X2011-01-01201110.1155/2011/693853693853Pseudolumen Size and Perimeter in Prostate Cancer: Correlation with Patient OutcomeKenneth A. Iczkowski0Kathleen C. Torkko1Gregory R. Kotnis2R. Storey Wilson3Wei Huang4Thomas M. Wheeler5Andrea M. Abeyta6M. Scott Lucia7Department of Pathology, University of Colorado Denver School of Medicine, Aurora, CO 80045, USADepartment of Pathology, University of Colorado Denver School of Medicine, Aurora, CO 80045, USADepartment of Pathology, University of Colorado Denver School of Medicine, Aurora, CO 80045, USADepartment of Pathology, University of Colorado Denver School of Medicine, Aurora, CO 80045, USADepartment of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI 53792, USADepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USADepartment of Pathology, University of Colorado Denver School of Medicine, Aurora, CO 80045, USADepartment of Pathology, University of Colorado Denver School of Medicine, Aurora, CO 80045, USAWe demonstrated in 2011 that 61% of men with postoperative PSA failure had some cribriform pattern of prostate cancer, versus 16% of nonfailures ( OR=5.89, 𝑃<.0001). That study used digitized radical prostatectomy slides from 153 men, 76 failures (≥0.2 ng/mL) matched to 77 nonfailures. The current study's hypothesis: pseudolumen size and shape variability could stratify outcome within histologic patterns (single separate acini, separate acini with undulating lumens, fused small acini, papillary, cribriform). Pseudolumens were filled digitally on image captures from previously annotated specimens. Among all 5 patterns, pseudolumen spaces averaged smaller in failures than nonfailures. After multivariate analysis controlling for stage, age, margin, cancer amount, prostate volume, and presence of individual cells (grade 5), this retained significance only for the undulating-lumens and papillary patterns. In undulating-lumens pattern, PSA failures had smaller mean pseudolumen space sizes (𝑃=.03) but larger perimeters (𝑃=.04), implying more pseudolumen irregularity. In papillary pattern, the number of pseudolumen spaces was higher in failures (𝑃=.015), space size was smaller (𝑃=.11), perimeters were smaller (𝑃=.04), and perimeter/size ratio was higher (𝑃=.02). In conclusion, digitally measured pseudolumen size and shape may associate with outcome.http://dx.doi.org/10.1155/2011/693853
spellingShingle Kenneth A. Iczkowski
Kathleen C. Torkko
Gregory R. Kotnis
R. Storey Wilson
Wei Huang
Thomas M. Wheeler
Andrea M. Abeyta
M. Scott Lucia
Pseudolumen Size and Perimeter in Prostate Cancer: Correlation with Patient Outcome
Prostate Cancer
title Pseudolumen Size and Perimeter in Prostate Cancer: Correlation with Patient Outcome
title_full Pseudolumen Size and Perimeter in Prostate Cancer: Correlation with Patient Outcome
title_fullStr Pseudolumen Size and Perimeter in Prostate Cancer: Correlation with Patient Outcome
title_full_unstemmed Pseudolumen Size and Perimeter in Prostate Cancer: Correlation with Patient Outcome
title_short Pseudolumen Size and Perimeter in Prostate Cancer: Correlation with Patient Outcome
title_sort pseudolumen size and perimeter in prostate cancer correlation with patient outcome
url http://dx.doi.org/10.1155/2011/693853
work_keys_str_mv AT kennethaiczkowski pseudolumensizeandperimeterinprostatecancercorrelationwithpatientoutcome
AT kathleenctorkko pseudolumensizeandperimeterinprostatecancercorrelationwithpatientoutcome
AT gregoryrkotnis pseudolumensizeandperimeterinprostatecancercorrelationwithpatientoutcome
AT rstoreywilson pseudolumensizeandperimeterinprostatecancercorrelationwithpatientoutcome
AT weihuang pseudolumensizeandperimeterinprostatecancercorrelationwithpatientoutcome
AT thomasmwheeler pseudolumensizeandperimeterinprostatecancercorrelationwithpatientoutcome
AT andreamabeyta pseudolumensizeandperimeterinprostatecancercorrelationwithpatientoutcome
AT mscottlucia pseudolumensizeandperimeterinprostatecancercorrelationwithpatientoutcome